San Francisco Sentry Investment Group CA bought a new position in Monsanto Company (NYSE:MON) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 2,024 shares of the basic materials company’s stock, valued at approximately $240,000.

Several other institutional investors have also bought and sold shares of MON. Pinnacle Financial Partners Inc. bought a new stake in shares of Monsanto in the 2nd quarter worth $114,000. Bruderman Asset Management LLC bought a new stake in shares of Monsanto in the 2nd quarter worth $116,000. JNBA Financial Advisors increased its holdings in shares of Monsanto by 3.9% in the 1st quarter. JNBA Financial Advisors now owns 1,193 shares of the basic materials company’s stock worth $135,000 after purchasing an additional 45 shares in the last quarter. Armbruster Capital Management Inc. increased its holdings in shares of Monsanto by 12.2% in the 2nd quarter. Armbruster Capital Management Inc. now owns 1,147 shares of the basic materials company’s stock worth $136,000 after purchasing an additional 125 shares in the last quarter. Finally, Penserra Capital Management LLC increased its holdings in shares of Monsanto by 9.5% in the 1st quarter. Penserra Capital Management LLC now owns 1,288 shares of the basic materials company’s stock worth $145,000 after purchasing an additional 112 shares in the last quarter. 74.81% of the stock is owned by institutional investors and hedge funds.

A number of analysts have commented on the company. Barclays PLC lifted their target price on Monsanto from $120.00 to $124.00 and gave the stock an “equal weight” rating in a report on Thursday. BMO Capital Markets reissued a “buy” rating and issued a $128.00 target price on shares of Monsanto in a report on Thursday. Macquarie lowered Monsanto from an “outperform” rating to a “neutral” rating in a report on Wednesday. BidaskClub raised Monsanto from a “sell” rating to a “hold” rating in a report on Thursday, June 29th. Finally, Royal Bank Of Canada reissued a “sector perform” rating and issued a $128.00 target price (up previously from $120.00) on shares of Monsanto in a report on Thursday, June 29th. Ten investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Monsanto has an average rating of “Hold” and an average price target of $125.64.

In other news, VP Duraiswami Narain sold 2,860 shares of the firm’s stock in a transaction dated Monday, September 25th. The stock was sold at an average price of $120.00, for a total transaction of $343,200.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, COO Brett D. Begemann sold 22,640 shares of the firm’s stock in a transaction dated Monday, September 25th. The shares were sold at an average price of $120.03, for a total value of $2,717,479.20. Following the sale, the chief operating officer now owns 85,439 shares in the company, valued at $10,255,243.17. The disclosure for this sale can be found here. Insiders have sold a total of 77,910 shares of company stock worth $9,242,439 over the last 90 days. Insiders own 0.79% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “San Francisco Sentry Investment Group CA Buys New Holdings in Monsanto Company (MON)” was originally reported by Watch List News and is the property of of Watch List News. If you are accessing this news story on another domain, it was copied illegally and republished in violation of United States & international copyright legislation. The original version of this news story can be viewed at https://www.watchlistnews.com/san-francisco-sentry-investment-group-ca-buys-new-holdings-in-monsanto-company-mon/1612923.html.

Monsanto Company (NYSE MON) traded down 0.43% during mid-day trading on Friday, reaching $119.35. The company’s stock had a trading volume of 350,254 shares. Monsanto Company has a one year low of $97.35 and a one year high of $120.50. The company has a market capitalization of $52.43 billion, a price-to-earnings ratio of 25.78 and a beta of 1.07. The stock has a 50-day moving average price of $118.18 and a 200-day moving average price of $117.00. Monsanto also was the recipient of some unusual options trading on Wednesday. Traders bought 63,484 put options on the company. This represents an increase of 1,793% compared to the typical daily volume of 3,354 put options.

Monsanto (NYSE:MON) last posted its earnings results on Wednesday, October 4th. The basic materials company reported $0.20 EPS for the quarter, beating the Zacks’ consensus estimate of ($0.41) by $0.61. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The firm had revenue of $2.69 billion for the quarter, compared to analysts’ expectations of $2.51 billion. During the same period last year, the firm earned $0.07 EPS. The company’s quarterly revenue was up 4.8% on a year-over-year basis. Equities research analysts forecast that Monsanto Company will post $5.60 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, October 6th will be given a dividend of $0.54 per share. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.80%. The ex-dividend date of this dividend is Thursday, October 5th. Monsanto’s dividend payout ratio (DPR) is presently 42.27%.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with Analyst Ratings Network's FREE daily email newsletter.